Medicare Denied Cancer Treatment — Oncology Coverage Rights for Seniors

A cancer diagnosis is frightening enough without the added shock of an insurance denial. Yet Medicare and Medicare Advantage plans do deny cancer treatment claims — sometimes for chemotherapy, radiation, immunotherapy, targeted therapy, or clinical trial participation. These denials can feel devastating.

You have the right to appeal. And when cancer treatment is at stake, the appeals process includes expedited options designed for urgent medical situations.

What Medicare Covers for Cancer Treatment

Medicare provides broad coverage for oncology services:

Medicare Part A covers inpatient hospital stays when cancer treatment requires hospitalization, including inpatient surgery and inpatient chemotherapy.

Medicare Part B covers outpatient cancer treatment including:

• Chemotherapy administered in a physician's office or outpatient hospital setting
• Radiation therapy (external beam, stereotactic body radiation, brachytherapy)
• Many injectable and infused oncology drugs administered by a healthcare provider
• Anti-nausea drugs administered with chemotherapy
• Some oral chemotherapy drugs when an equivalent IV formulation is also covered

Medicare Part D covers oral chemotherapy medications, targeted therapy pills, and other oral cancer drugs available at pharmacies. Coverage specifics depend on your Part D plan's formulary.

Clinical trials: Medicare has explicit coverage for routine costs in qualifying cancer clinical trials. This is a significant protection — you should not have to choose between experimental treatment and Medicare coverage for standard care costs.

Why Cancer Treatment Claims Get Denied

Off-label drug use. Many chemotherapy and targeted therapy drugs are used for cancer types not listed in their FDA approval. Medicare Part B should cover off-label uses that are supported by widely accepted compendia — such as NCCN (National Comprehensive Cancer Network) guidelines, Drugdex, or Clinical Pharmacology. If a denial cites "off-label use," your oncologist can support the appeal by citing the relevant compendium listing.

Prior Authorization Denied: How to Appeal" class="auto-link">Prior authorization issues. Medicare Advantage plans require prior authorization for many cancer drugs and procedures. If authorization wasn't obtained, or if it was obtained but the plan is denying anyway, document every step and include proof of authorization in your appeal.

Medical necessity disputes. For certain procedures — like PET scans, bone marrow biopsies, or reconstructive surgery after mastectomy — the plan may claim the service wasn't medically necessary for your situation. Your oncologist's documentation is key to countering this.

Step therapy requirements. Some Medicare Advantage plans require you to try certain drugs before approving more expensive ones. For cancer patients, step therapy is often inappropriate, and CMS has issued guidance restricting its use for serious conditions. Your oncologist can request a step therapy override.

Part D formulary denials. Your drug plan may not include your oral cancer medication on its formulary, or it may place it in a high cost-sharing tier. You have the right to request a formulary exception for medically necessary drugs not on the formulary.

Expedited Appeals for Urgent Situations

If your cancer treatment is being denied and your health condition requires a quick decision, you have the right to request an expedited appeal. For Medicare Advantage:

• Standard appeal: Plan must respond within 30 days
• Expedited appeal: Plan must respond within 72 hours when a standard timeline would seriously jeopardize your health

Ask your oncologist to support the expedited request by documenting in writing why the standard timeline would be harmful — for example, that a delay in starting chemotherapy would allow the cancer to progress, or that you are in the middle of a treatment cycle.

Building a Strong Oncology Appeal

Your oncologist's letter is everything. A detailed Letter of Medical Necessity from your cancer doctor, directly addressing the denial reason, is the most persuasive document in an oncology appeal. Ask your oncologist to include:

• Your specific diagnosis and stage
• The treatment requested and its FDA approval status or compendium support
• Why this treatment is appropriate for your case
• What alternatives were considered and why they are insufficient
• The risk of not receiving this treatment in a timely way

NCCN Guidelines. The National Comprehensive Cancer Network publishes evidence-based treatment guidelines for every major cancer type. If your treatment aligns with NCCN recommendations, cite the specific guideline. These guidelines carry significant weight in appeals.

Peer-to-peer review. Ask your oncologist to request a peer-to-peer review with the insurer's medical director. This is a direct physician-to-physician conversation and often results in a reversal without a formal appeal proceeding.

Second opinion letter. If you've seen another oncologist or a major cancer center, a supporting letter from a second physician adds weight to your case.

File a Complaint If Treatment Is Delayed

If a Medicare Advantage plan is delaying cancer treatment through slow appeals processing or repeated administrative hurdles, file a complaint with CMS. You can call 1-800-MEDICARE or use Medicare.gov. CMS takes treatment delay complaints seriously, particularly for serious conditions.

The Office of Inspector General also accepts complaints about Medicare fraud and abuse, which can include plans that systematically deny medically necessary cancer care.

Fight Back With ClaimBack

When cancer treatment is on the line, you need an appeal that is thorough, professional, and submitted without delay. ClaimBack helps cancer patients and their families build complete appeal letters that directly address every denial reason — so you can focus on your health while fighting for your coverage.

Start your appeal at ClaimBack

Related Reading

• What Is Medical Necessity?
• How to Write an Insurance Appeal Letter
• Internal vs. External Insurance Appeals